We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We believe how we deliver is just as important as what we deliver.
We invest in building brands that consumers trust and come back to, time and time again.
We produce treatments for a wide range of conditions as well as more than 30 vaccines worldwide.
ViiV Healthcare is a global specialist HIV company dedicated to delivering advances in treatment and care for people living with HIV.
Search for jobs and graduate positions across the world of GSK.
You're ready to apply. Read about how you can make your application stand out.
Our people are essential to our success. We focus on building their capabilities, and aim to support and empower them to be the best they can be.
Applications for the 2021 IBL intake have now closed. Applications for the 2022 intake will open in July 2021.
Our open innovation strategy is designed to promote change beyond GSK by sharing expertise, resources intellectual property and know-how with external researchers and the scientific community in Australia and across the globe.
Regardless of whether clinical trials deliver positive or negative results, we are committed to sharing our research and collaborating with others so that we can advance our understanding of medicines and over-the-counter healthcare products.
There are typically four phases to clinical trials. GSK Australia is involved in all aspects of these phases.
We are committed to discovering and developing new medicines and vaccines, not just through our own clinical development, but also by investing in local research initiatives that are aligned with our vision and values.
Metabolic diseases are fast becoming a silent but global pandemic. Research demonstrates that over 60% of cancers are linked to obesity1 and Type 2 diabetes costs the Australian health care system more than $6 billion annually and affects more than 1.5 million Australians2.
We bring health benefits to people around the world through our open, flexible and collaborative approach to innovation and access to healthcare.
How we do things is just as important as what we do. We have designed our values based culture to ensure we put patients and consumers first every time.
Our people and the communities in which they operate are essential to our success. We focus on building their individual capabilities and aim to support and empower them to be the best they can be.
We are working hard to reduce our environmental footprint. We aim to grow our business while protecting the natural; resources we need for the future.
At GSK we are global advocates for increased transparency in the pharmaceutical industry. We believe in being ethical and responsible in everything we do.
Access and download our corporate responsibility reports here.
Our commitment to social responsibility, globally and in the Australian community, is embedded into the way we do business, and we are proud to build our Reconciliation Action Plan (RAP) into our ways of working.
No terms
The information you are about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the company or via the Product Information.
